Form 8-K - Current report:
SEC Accession No. 0001104659-24-115049
Filing Date
2024-11-07
Accepted
2024-11-07 07:05:12
Documents
16
Period of Report
2024-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2427743d1_8k.htm   iXBRL 8-K 29293
2 EXHIBIT 10.1 tm2427743d1_ex10-1.htm EX-10.1 95450
3 EXHIBIT 99.1 tm2427743d1_ex99-1.htm EX-99.1 117332
4 GRAPHIC tm2427743d1_ex10-1img01.jpg GRAPHIC 13615
  Complete submission text file 0001104659-24-115049.txt   470506

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA trvn-20241105.xsd EX-101.SCH 3021
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE trvn-20241105_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trvn-20241105_pre.xml EX-101.PRE 22363
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2427743d1_8k_htm.xml XML 3567
Mailing Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087
Business Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087 6103548840
TREVENA INC (Filer) CIK: 0001429560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36193 | Film No.: 241433092
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)